Latest News, Events, & Information from Galaxy Medical
SAN CARLOS, CA, Mar. 16, 2021 - ATP, a leader in life science venture capital, announced today $18M in Series A financing for its portfolio company Galaxy Medical, Inc. The funds are being used to advance the development of Galaxy's flagship product CENTAURI™, which uses Pulsed Electric Field (PEF) technology to treat cardiac arrhythmias.
SAN CARLOS, CA, Jan. 20, 2021 - Galaxy Medical, a developer of Pulsed Electric Field (PEF) technology for the treatment of cardiac arrhythmias, today announced that the proprietary CENTAURI™ System will be featured in a recorded case presentation on Sunday, January 31st during the upcoming
First Patients Treated with Galaxy Medical's Centauri™ Pulsed Electric Field Cardiac Ablation System
SAN CARLOS, CA, Oct. 8, 2020 - Galaxy Medical, a developer of Pulsed Electric Field (PEF) technology for the treatment of cardiac arrhythmias, today announced that the first patients in the ECLIPSE-AF study were successfully treated with the proprietary Centauri™ System by Dr. Ante Anić in Split, Croatia. This multicenter trial is designed to assess the safety and efficacy of the Centauri System and is intended to support CE-Mark.